Eiko Lifesciences accepts Hasti Doshi's resignation as independent director
- Eiko Lifesciences accepted Hasti Doshi's resignation as Independent Director
- Effective date is August 24, 2026, citing other career commitments
- Her term was originally set to end on September 3, 2029
- She holds no directorships in other listed entities
*this image is generated using AI for illustrative purposes only.
Eiko Lifesciences has accepted the resignation of Ms. Hasti Doshi from the position of Independent Director on its Board. The change is effective from the closing of business hours on August 24, 2026.
Ms. Doshi, identified by DIN 10757758, cited other career commitments requiring her time and attention as the reason for stepping down. Her original term was scheduled to conclude on September 3, 2029.
Board Approval and Regulatory Compliance
The Board of Directors of Eiko Lifesciences considered and approved the resignation during its meeting held on August 24, 2026. The company disclosed the development pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The disclosure aligns with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. Chintan Doshi, the Company Secretary and Compliance Officer, confirmed the acceptance to the BSE Limited.
Resignation Details
In her resignation letter, Ms. Doshi confirmed that there are no material reasons for her departure other than the stated career commitments. She thanked the Board and the company for the support extended during her tenure.
| Particular | Details |
|---|---|
| Resigning Director | Ms. Hasti Doshi (DIN: 10757758) |
| Position Held | Independent Director |
| Effective Date | August 24, 2026 |
| Reason | Other career commitments |
| Original Term End | September 3, 2029 |
| Other Listed Directorships | Nil |
Ms. Doshi does not hold directorships in any other listed entities. The Board has been requested to update statutory records and inform relevant regulatory authorities accordingly.
Historical Stock Returns for EIKO Lifesciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.31% | -1.65% | -6.92% | -11.86% | -18.63% | 0.0% |
Will Eiko Lifesciences initiate an immediate search for a replacement Independent Director to maintain board composition compliance?
How might the departure of Ms. Doshi impact the company's governance structure given her original term was scheduled to last until 2029?
Are there any pending strategic decisions or regulatory approvals where Ms. Doshi's independent oversight was particularly critical?
15
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
